Servier India secures CDSCO approval for Vorasidenib for Grade 2 IDH-mutant glioma
Approval enables access to targeted therapy for adults and adolescents aged 12 and above following surgery
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CDSCO approval
IQVIA India secures CDSCO CRO registration, reinforces leadership in clinical research
IQVIA India’s CDSCO CRO registration reinforces its role in strengthening clinical trial standards and supporting India’s growing…
HiMedia Laboratories receives CDSCO approval for Hepatitis B and C Molecular Diagnostic Kits
The Hi-PCR® Hepatitis B and C detection and quantitation kits will now be manufactured in India under CDSCO approval, supporting…
NovaLead’s patented repurposed drug gets CDSCO nod for DFU patients in India
The drug is a novel topical gel formulation of Esmolol hydrochloride
CDSCO approves AstraZeneca’s Dapagliflozin with additional indication for treating CKD and heart…
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalisation for heart failure in adults with…
CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure
It's the first treatment for heart failure with preserved ejection fraction (HFpEF) in India
Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India
Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…